Who invested in Gilgamesh Pharmaceuticals?
Gilgamesh Pharmaceuticals's investors include Y Combinator, Alumni Ventures, Gaingels, Bossa Invest and Pioneer Fund.
United States · Series A startup
2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 8 months ago
Funding summaryUpdated 26 Oct 2026
$66Mraised across 2 rounds since 2026, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded and 1 otherSEC filing: $60M sold, first sale Mar 2026
Source recorded and 1 otherSEC filing: $6.1M sold, first sale Jan 2026
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Gilgamesh Pharmaceuticals's investors include Y Combinator, Alumni Ventures, Gaingels, Bossa Invest and Pioneer Fund.
Gilgamesh Pharmaceuticals has raised $66M across 2 rounds since 2026.
Gilgamesh Pharmaceuticals's most recent round was a Series A of $60M in Mar 2026.
Its most recent round, $60M in Mar 2026, is also its largest on record.
Gilgamesh Pharmaceuticals's first round on record, in Feb 2026, was backed by Y Combinator, Alumni Ventures and Gaingels and 2 others.
Gilgamesh Pharmaceuticals's latest named round is a Series A, in Mar 2026.
Gilgamesh Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.